Table 2.
Duration of step counter use and mean daily steps.
| Step counter use | All patients | Activity level (steps/day) | P | ||||
|
|
|
Low (<2999) | Medium (3000-9999) | High (≥10,000) |
|
||
| Duration of use |
|
|
|
|
|
||
|
|
Total days, mean (SD) | 160 (100) | 109 (56) | 168 (103) | 208 (112) | .04a,b | |
|
|
Active days, mean (SD) | 139 (93) | 79 (26) | 148 (97) | 189 (102) | .006a,c | |
|
|
Active days/total days, % | 87 | 72 | 88 | 91 |
|
|
| Walking activity (steps/day), mean (SD) |
|
|
|
|
|
||
|
|
Grand mean | 5899 (3151) | 1996 (716) | 6016 (1784) | 11,439 (440) |
|
|
|
|
Gender |
|
|
|
|
.82a | |
|
|
|
Male | 5853 (3274) | 2064 (696) | 6008 (1785) | 11,430 (469) |
|
|
|
|
Female | 6078 (2725) | 1105 (0) | 6037 (1869) | 11,501 (0) |
|
|
|
Week |
|
|
|
|
.004d | |
|
|
|
Week 1 (7 days) | 5191 (3198) | 1578 (500) | 5366 (2306) | 9611 (2995) |
|
|
|
|
Week 4 (30 days) | 6362 (3834) | 1807 (780) | 6305 (2536) | 12,697 (1678) |
|
|
|
|
Week 13 (90 days) | 6186 (3013) | 2304 (1189) | 6073 (2271) | 10,637 (1095) |
|
|
|
|
Week 26 (180 days) | 6794 (3518) | 808 (0) | 6506 (3569) | 9011 (884) |
|
|
|
|
Week 39 (270 days) | 8235 (4220) | 0 (0) | 5960 (2461) | 12,784 (3127) |
|
|
|
|
Week 52 (365 days) | 7890 (2629) | 0 (0) | 7426 (2730) | 9050 (2811) |
|
|
|
Primary diagnose or treatment |
|
|
|
|
.12a | |
|
|
|
ACSe | 6549 (3149) | 2194 (712) | 6127 (1558) | 11,588 (354) |
|
|
|
|
Surgeryf | 4781 (3023) | 1879 (653) | 6058 (845) | 0 (0) |
|
|
|
|
Heart failure | 7340 (3190) | 2636 (0) | 5949 (2605) | 10,916 (306) |
|
|
|
|
ACS & heart failure | 4505 (163) | 865 (0) | 5415 (845) | 0 (0) |
|
|
|
Cardiac telerehabilitation |
|
|
|
|
.34a | |
|
|
|
Health care center | 5324 (2579) | 2197 (585) | 5779 (1243) | 11,737 (333) |
|
|
|
|
Hospital | 6128 (3084) | 2082 (980) | 5950 ( 2242) | 11,187 (518) |
|
|
|
|
Call center | 6847 (4353) | 1578 (751) | 7485 (1608) | 11,478 (418) |
|
a P value for comparison of all three activity groups (low, medium, and high).
b Post hoc 2-sample Wilcoxon rank-sum test values: low versus medium activity groups (P=.05), low versus high activity groups (P=.01), and medium versus high activity groups (P=.22).
c Post hoc 2-sample Wilcoxon rank-sum values: low versus medium activity groups (P=.01), low versus high activity groups (P=.003), and medium versus high activity groups (P=.21).
d P value for correlation between termination of step counter use and mean steps walked at the specified days.
e ACS: acute coronary syndrome.
f Surgery includes valve replacement, mitral valve repair, and coronary artery bypass grafting.